Related Experiment Video
Updated: Nov 13, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Cardiovascular Injury Due to SARS-CoV-2
Christina L Bugert1, Victoria Kwiat2, Isela C Valera2
1College of Life and Environmental Sciences, University of Exeter, Exeter, South West UK.
COVID-19, caused by the novel coronavirus SARS-CoV-2, presents varied symptoms. This review examines myocardial injury in COVID-19 patients, covering causes, treatments, and future research directions for cardiac risk.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, presents a significant global health challenge.
- While respiratory symptoms are common, SARS-CoV-2 infection is increasingly linked to diverse clinical manifestations, including cardiac complications.
- Myocardial injury is a recognized concern in COVID-19 patients, particularly those with severe disease.
Purpose of the Study:
- To review the direct and indirect causes of myocardial injury in patients with COVID-19.
- To summarize current knowledge regarding the cardiovascular impact of SARS-CoV-2 infection.
- To highlight existing treatment strategies and identify areas for future research.
Main Methods:
- Literature review of studies on COVID-19 and cardiovascular involvement.
- Analysis of data on the incidence and mechanisms of myocardial injury in COVID-19 patients.
- Synthesis of information on clinical management and therapeutic approaches.
Main Results:
- Emerging data confirm that SARS-CoV-2 infection can lead to myocarditis and increase cardiac risk.
- Cardiac injury is more prevalent in severe COVID-19 cases and among patients in intensive care units.
- Understanding the heterogeneity of COVID-19 manifestations is crucial for managing cardiac complications.
Conclusions:
- Tailored pharmacological treatments and patient management strategies have improved COVID-19 mortality rates.
- Ongoing research is essential to further elucidate the mechanisms of myocardial injury in COVID-19.
- Effective strategies to mitigate cardiac injury in COVID-19 patients are a key focus for clinical practice and research.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
